KUROBE PHARMACEUTICALS
Kurobe, headquartered in Tampa, has licensed a product from a Japanese company to treat methicillin-resistant staphylococcus aureus (MRSA) in the eye, said Barry Butler, president and CEO. Kurobe is one of several companies under the umbrella of Point Guard Partners LLC, established by former management executives at Sirion Holdings Inc. after that Tampa-based biopharma firm was sold in 2010. Butler, who was CEO of Sirion, is managing partner of Point Guard.
KUROBE PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Tampa, Florida, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
5 M USD
Current Employees Featured
